WO2014053625A3 - Propionibacterium freudenreichii as an active agent against skin disorders - Google Patents

Propionibacterium freudenreichii as an active agent against skin disorders Download PDF

Info

Publication number
WO2014053625A3
WO2014053625A3 PCT/EP2013/070681 EP2013070681W WO2014053625A3 WO 2014053625 A3 WO2014053625 A3 WO 2014053625A3 EP 2013070681 W EP2013070681 W EP 2013070681W WO 2014053625 A3 WO2014053625 A3 WO 2014053625A3
Authority
WO
WIPO (PCT)
Prior art keywords
active agent
propionibacterium freudenreichii
skin disorders
agent against
against skin
Prior art date
Application number
PCT/EP2013/070681
Other languages
French (fr)
Other versions
WO2014053625A2 (en
Inventor
Audrey Gueniche
Maria Dalko
Lionel Breton
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2014053625A2 publication Critical patent/WO2014053625A2/en
Publication of WO2014053625A3 publication Critical patent/WO2014053625A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Abstract

The invention relates in particular to the use of a culture supernatant or lysate of at least one micro-organism of the Propionibacterium freudenreichii species as an agent for the treatment and/or prevention of scalp disorders.
PCT/EP2013/070681 2012-10-05 2013-10-04 Propionibacterium freudenreichii as an active agent against skin disorders WO2014053625A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1259521A FR2996450B1 (en) 2012-10-05 2012-10-05 PROPIONIBACTERIUM FREUDENREICHII AS AN AGENT AGAINST SKIN DISORDERS
FR1259521 2012-10-05
US201361757916P 2013-01-29 2013-01-29
US61/757,916 2013-01-29

Publications (2)

Publication Number Publication Date
WO2014053625A2 WO2014053625A2 (en) 2014-04-10
WO2014053625A3 true WO2014053625A3 (en) 2014-10-23

Family

ID=47833096

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2013/070681 WO2014053625A2 (en) 2012-10-05 2013-10-04 Propionibacterium freudenreichii as an active agent against skin disorders

Country Status (2)

Country Link
FR (1) FR2996450B1 (en)
WO (1) WO2014053625A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3124077A1 (en) * 2021-06-22 2022-12-23 Nanyang Technological University Use of a short chain fatty acid as an antidandruff agent

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912917A1 (en) * 2007-02-26 2008-08-29 Oreal CONDITIONED MEDIUM AND USES THEREOF
FR2938429A1 (en) * 2008-11-19 2010-05-21 Oreal Use of as cosmetic agent of probiotic microorganism in particular of Lactobacillus and Bifidobacterium species genus, for treating scalp disorders e.g. dandruff condition, pruritis or seborrhoeic dermatitis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3024318A1 (en) 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin COSMETIC AGENTS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912917A1 (en) * 2007-02-26 2008-08-29 Oreal CONDITIONED MEDIUM AND USES THEREOF
FR2938429A1 (en) * 2008-11-19 2010-05-21 Oreal Use of as cosmetic agent of probiotic microorganism in particular of Lactobacillus and Bifidobacterium species genus, for treating scalp disorders e.g. dandruff condition, pruritis or seborrhoeic dermatitis

Also Published As

Publication number Publication date
FR2996450B1 (en) 2017-01-13
WO2014053625A2 (en) 2014-04-10
FR2996450A1 (en) 2014-04-11

Similar Documents

Publication Publication Date Title
PH12017502298B1 (en) Antibacterial compounds
EP3270938A4 (en) Methods and compositions relating to microbial treatment and diagnosis of skin disorders
CA2900779C (en) Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
PT2848097T (en) Device for the plasma treatment of human, animal or plant surfaces, in particular of skin or mucous membrane areas
WO2012062925A3 (en) Compounds and methods for treating pain
EP2827837B8 (en) Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails
NZ727304A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
EP3139939A4 (en) Compositions and methods for treating skin and mucous membrane diseases
HK1198921A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof dgla15-ohepa / 15-hetre
WO2013098416A3 (en) Pain relief compounds
MX367091B (en) TOPICAL COMPOSITIONS and METHODS OF USE.
EP3151923A4 (en) Clear compositions and methods for the delivery of active ingredients for skin care
WO2013174774A3 (en) Cosmetic compositions comprising magnetosomes and uses thereof
EP3228626A4 (en) Peptide having activity to improve skin condition and use thereof
WO2013114394A8 (en) A polyherbal composition for skin care
EP3185862A4 (en) Protective metallothionein analog compounds, their compositions and use thereof in the treatment of pathogenic diseases
WO2012024399A3 (en) Compositions comprising paulownin and/or paulownia extracts and uses thereof
EP2910247A4 (en) Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients
WO2011103028A3 (en) Compositions and methods for inhibiting mmset
WO2014009315A3 (en) Use of zinc coceth sulfate as an antibacterial agent against propionibacterium acnes
WO2014053625A3 (en) Propionibacterium freudenreichii as an active agent against skin disorders
EP3397286A4 (en) Compositions and methods to affect skin irritation
EP3065548A4 (en) Fibrosis inhibiting compounds and methods of use thereof in the prevention or treatment of fibrosing diseases

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13773724

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 13773724

Country of ref document: EP

Kind code of ref document: A2